Borrás C - Search Results

1

Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS.

Tintoré M, Rovira A, Brieva L, Grivé E, Jardí R, Borrás C, Montalban X. Tintoré M, et al. Among authors: borras c. Mult Scler. 2001 Dec;7(6):359-63. doi: 10.1177/135245850100700603. Mult Scler. 2001. PMID: 11795456

2

A longitudinal study of cognition in primary progressive multiple sclerosis.

Camp SJ, Stevenson VL, Thompson AJ, Ingle GT, Miller DH, Borras C, Brochet B, Dousset V, Falautano M, Filippi M, Kalkers NF, Montalban X, Polman CH, Langdon DW. Camp SJ, et al. Among authors: borras c. Brain. 2005 Dec;128(Pt 12):2891-8. doi: 10.1093/brain/awh602. Epub 2005 Jul 27. Brain. 2005. PMID: 16049040

3

Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.

Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Hérissé-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW. Camp SJ, et al. Among authors: borras c. Brain. 1999 Jul;122 ( Pt 7):1341-8. doi: 10.1093/brain/122.7.1341. Brain. 1999. PMID: 10388799

4

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.

Montalban X, Sastre-Garriga J, Tintoré M, Brieva L, Aymerich FX, Río J, Porcel J, Borràs C, Nos C, Rovira A. Montalban X, et al. Among authors: borras c. Mult Scler. 2009 Oct;15(10):1195-205. doi: 10.1177/1352458509106937. Epub 2009 Sep 29. Mult Scler. 2009. PMID: 19797261 Clinical Trial.

5

Long-term emotional state of multiple sclerosis patients treated with interferon beta.

Porcel J, Río J, Sánchez-Betancourt A, Arévalo MJ, Tintoré M, Téllez N, Borràs C, Nos C, Montalbán X. Porcel J, et al. Among authors: borras c. Mult Scler. 2006 Dec;12(6):802-7. doi: 10.1177/1352458506070748. Mult Scler. 2006. PMID: 17263010

6

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Tintoré M, Rovira A, Martínez MJ, Rio J, Díaz-Villoslada P, Brieva L, Borrás C, Grivé E, Capellades J, Montalban X. Tintoré M, et al. Among authors: borras c. AJNR Am J Neuroradiol. 2000 Apr;21(4):702-6. AJNR Am J Neuroradiol. 2000. PMID: 10782781 Free PMC article.

7

[Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b].

Río J, Marzo ME, Tintoré M, Borrás C, Montalbán X. Río J, et al. Among authors: borras c. Neurologia. 1998 Nov;13(9):422-6. Neurologia. 1998. PMID: 9883016 Clinical Trial. Spanish.

8

Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials.

Río J, Nos C, Tintoré M, Borrás C, Galán I, Comabella M, Montalban X. Río J, et al. Among authors: borras c. Ann Neurol. 2002 Oct;52(4):400-6. doi: 10.1002/ana.10290. Ann Neurol. 2002. PMID: 12325067 Clinical Trial.

9

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

Nos C, Sastre-Garriga J, Borràs C, Río J, Tintoré M, Montalban X. Nos C, et al. Among authors: borras c. Mult Scler. 2004 Aug;10(4):413-6. doi: 10.1191/1352458504ms1068oa. Mult Scler. 2004. PMID: 15327039

10

Amelioration of flulike symptoms at the onset of interferon beta-1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction.

Martínez-Cáceres EM, Río J, Barrau M, Durán I, Borrás C, Tintoré M, Montalban X. Martínez-Cáceres EM, et al. Among authors: borras c. Ann Neurol. 1998 Oct;44(4):682-5. doi: 10.1002/ana.410440415. Ann Neurol. 1998. PMID: 9778268 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results